Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

© 2012 Springer-Verlag London Limited. Ischemic heart disease is a major cause of morbidity and mortality in the Western world. It occurs when oxygen delivery cannot meet the metabolic needs of the heart, as observed in patients with stable coronary artery disease as well as those experiencing acute myocardial infarction. Although conditions leading to myocardial injury have been well studied, and physical means of revascularization by stenting or coronary bypass surgery are well developed, there remains a need to define treatments that limit damage in the acute phase or promote revascularization by medical means. In particular, mechanisms that preserve cellular function during ischemia remain poorly understood.

Original publication

DOI

10.1007/978-0-85729-920-8_2

Type

Chapter

Book title

Translational Vascular Medicine: Pathogenesis, Diagnosis, and Treatment

Publication Date

01/11/2013

Volume

9780857299208

Pages

17 - 25